Geometry.Net - Health_Conditions: Prostatic Hypertrophy


Home - Health_Conditions - Prostatic Hypertrophy

e99.com Bookstore

Images

Newsgroups

101-111 of 111 Back | 1 | 2 | 3 | 4 | 5 | 6

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Prostatic Hypertrophy: more books (75)

Benign prostatic hyperplasia by William D Steers, 1995
Enlargement of the prostate: Its history, anatomy, Ã¦tiology, pathology, clinical causes, symptoms, diagnosis, prognosis, treatment, technique of operations, and after-treatment by John B Deaver, 1905
Fundamental Approaches to the Diagnosis & Treatment for Prostate Cancer and Bph: Proceedings of the Fifth Tokyo Symposium on Prostate Cancer, Decemb by Kyoichi, M.D. Imai, Jun, M.D. Shimazaki, 1994-10
Recent Advances in Prostate Cancer and BPH

lists with details

Alpha Blocker Prazosin For The Treatment Of Benign Prostatic Hypertrophy (BPH).
Alpha blocker prazosin for the treatment of benign prostatic hypertrophy (BPH). Punekar SV, Kelkar AR, Gavande PM, Rao NR, Date JA, Prem AR
http://www.jpgmonline.com/article.asp?issn=0022-3859;year=1995;volume=41;issue=4
Project: Cost-effectiveness Analysis Of Different Treatment Modalities Of Benign
Abstract, Economic analysis in the context of a randomized controlled trial, studying different strategies in the treatment of benign prostatic hypertrophy.
http://www.onderzoekinformatie.nl/en/oi/nod/onderzoek/OND1263629/toon

Extractions: Login English KNAW Research Information NOD - Dutch Research Database ... Research entire www.onderzoekinformatie.nl site fuzzy match Print View Titel Kosten-effectiviteitsanalyse van thermotherapie met en zonder medicamenteuze adjuvante therapie bij Benigne Prostaat Hypertrofie (BPH) en kosten effectiviteitsanalyse van thermotherapie vs. transureH Abstract Economic analysis in the context of a randomized controlled trial, studying different strategies in the treatment of benign prostatic hypertrophy. Period 08/1994 - unknown Related organisations
Doxazosin GITS Effective In Benign Prostatic Hypertrophy
Doxazosin GITS Effective in Benign prostatic hypertrophy Presented at ICPC By Jill Stein. PARIS, FRANCE July 1, 2005 Treatment with a doxazosin
http://www.pslgroup.com/dg/24ec52.htm
Benign Prostatic Hyperplasia - Patient UK
Benign prostatic hypertrophy. Synonyms benign prostatic hyperplasia; benign prostatic obstruction; benign prostatic enlargement.
http://www.patient.co.uk/showdoc/40000252/

Extractions: PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people. Benign prostatic enlargement, BPH Benign prostatic hypertrophy is an increase in size of the prostate gland that is so common as to be normal with advancing age and there is no malignancy present. Enlargement is by an increase in the number of glandular units, called hyperplasia , as is typical of glandular enlargement, rather than a constant number of units that increase in size as in muscle hypertrophy . It seems likely that the nature of BPH is a failure of apoptosis and that some of the drugs used to treat it may induce that process.
Enlarged Prostate
Prostate enlargement is often called benign prostatic hypertrophy or hyperplasia (BPH). It is not cancer and it does not put you at increased risk for
http://www.pennhealth.com/ency/article/000381.htm

Extractions: Appointments Medical Services Health Information Find a Doctor Search: Search Encyclopedia: List of Topics Print This Page Â Endocrinology, Male Urology Male reproductive anatomy BPH Prostatectomy - series TURP - series Definition: The prostate gland produces the fluid that carries sperm during ejaculation. As the prostate enlarges, which happens to almost all men as they get older, it can press on the urethra (the tube that empties urine from the bladder). This causes problems with urination. Prostate enlargement is often called benign prostatic hypertrophy or hyperplasia (BPH). It is not cancer and it does not put you at increased risk for prostate cancer. Alternative Names: BPH; Benign prostatic hypertrophy (hyperplasia); Prostate - enlarged Causes, incidence, and risk factors: The actual cause of prostate enlargement is unknown. In addition to age, overgrowth of the prostate seems to require normal function of the testicles, which produce testosterone. This is known because men who have had their testicles removed at a young age (for example, for testicular cancer) do not develop BPH. Similarly, if the testicles are removed after a man develops BPH, the prostate begins to shrink in size. The likelihood of developing an enlarged prostate increases with age. In fact, BPH is so common that it has been said, "All men will have an enlarged prostate if they live long enough!" A small amount of prostate enlargement is present in many men over age 40 and more than 90% of men over age 80. No risk factors have been identified other than having normally functioning testicles.
Benign Prostatic Hyperplasia (BPH)
Benign prostatic hyperplasia (BPH) is sometimes referred to as an enlarged BPH; Benign prostatic hypertrophy; Enlarged prostate; Prostate enlarged
http://www.shands.org/health/information/article/000381.htm

Extractions: Disease Injury Nutrition Poison ... TURP - series Definition: Benign prostatic hyperplasia (BPH) is sometimes referred to as an "enlarged prostate." BPH is a condition where benign (non-cancerous) nodules enlarge the prostate gland. The prostate gland produces the liquid in which sperm are expelled from the penis. Causes, incidence, and risk factors: The actual cause of benign prostatic hyperplasia (BPH) is unknown. However, men who have had their testicles removed do not develop BPH and, after castration, BPH has been observed to regress. In other words, the presence of normally functioning testicles appears to be necessary for the development of BPH. Abnormally growing prostate tissue may use male hormones differently than normal prostate tissue. Although this tissue growth is non-cancerous, as the tumor grows larger it can obstruct the urethra and interfere with the normal flow of urine. The incidence of BPH increases with advancing age. BPH is so common that it has been said, "All men will have benign prostatic hyperplasia if they live long enough!" A small amount of BPH is present in 80% of men over 40 years old and over 95% of men 80 years old. No risk factors have been identified other than having normally functioning testicles.
Benign Prostatic Hyperplasia (benign Enlargement Of The Prostate)
The prostate is a gland the size of a chestnut. It is only present in men, and it is situated under the bladder surrounding the urethra, the passageway that
http://www.netdoctor.co.uk/diseases/facts/prostaticenlargement.htm

Extractions: Search: All NetDoctor Diseases Medicines NetDoctor.co.uk Home News and features News News archive Newsletter Features Encyclopaedia Diseases Examinations Medicines Premium services SMS services StayQuit thediet Health centres ADHD Allergy and asthma Children's health Depression ... All health centres Discussion and support Discussion forums Support groups Services Ask the doctor Find a hospital Search Medline Test yourself Information About NetDoctor Commercial opportunities NetDoctor.com Benign prostatic hyperplasia (benign enlargement of the prostate) Reviewed by Mr John Macfarlane , consultant urological surgeon
Benign Prostate Hypertrophy | Doctor Solve
Prostate enlargement affects about half of men in their 60s and up to 90 percent of men in their 70s and 80s.
http://www.doctorsolve.com/ailments/BenignProstateHypertrophy.aspx

Extractions: @import url( /doctorsolve/includes/position.css ); Your internet source for Canadian drugs PHONE: 1.866.732.0305 FAX: 1.866.732.0306 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Check Drug Prices How to Order Refill a Prescription Print Order Form ... Research an Ailment We also offer: Pet Medication Over the Counter Need Assistance? Please direct all inquiries to our toll-free number: The information provided using this web site is only intended to be general summary information to the public.Â It is not intended to take the place of information given to you by your practitioner. More Research an Ailment Information: Epilepsy Fibromyalgia Heart Arrythmias Acne ... Read Our Newsletter Online Canadian Pharmacies Are they safe? Approved Canadian drugs are manufactured in TPD (Therapeutics Product Directorate) approved and licensed facilities under GMP (Good Manufacturing Practices) and meet all Canadian legal standards. The standards for Canadian drugs are among the most stringent in the world. You are here: Home Research an Ailment Benign Prostate Hypertrophy The prostate gland is located just below a male's bladder and surrounds the top portion of the tube that drains urine from the bladder (urethra). The gland's primary function is to produce most of the fluids in semen, the fluid that nourishes and transports sperm.
IngentaConnect Content Not Found
Benign prostate hypertrophy (BPH) is the most common benign tumor in men due to obstruction of the urethra and, finally, uremia. Malondialdehyde (MDA) is a
http://www.ingentaconnect.com/content/carfax/cmin/2003/00000012/00000002/art0001

Extractions: For Researchers For Librarians Unfortunately we are unable to locate the content you are looking for. It is possible that the publisher, journal or issue is no longer hosted at Ingenta, or that the link that brought you to this page is incorrect. We have located the journal: Mediators of Inflammation . To view content for this journal, click here Please use the browse or search features to find the content you are looking for. Terms and Conditions Quick Search
Mediators Of Inflammation
MALONDIALDEHYDE IN BENIGN PROSTATE hypertrophy A USEFUL MARKER? Benign prostate hypertrophy (BPH) is the most common benign tumor in men due to
http://www.hindawi.com/journals/mi/volume-12/S0962935103000176.html

Extractions: Home About this Journal Forthcoming Articles Author Index ... Contents MI 12:2 (2003) 127-128. DOI: 10.1155/S0962935103000176 MALONDIALDEHYDE IN BENIGN PROSTATE HYPERTROPHY: A USEFUL MARKER? ROSARIA ALBA MERENDINO, FRANCESCO SALVO, ANTONELLA SAIJA, GIUSEPPE DI PASQUALE, ANTONIO TOMAINO, PAOLA LUCIA MINCIULLO, GIUSEPPE FRACCICA, and SEBASTIANO GANGEMI Benign prostate hypertrophy (BPH) is the most common benign tumor in men due to obstruction of the urethra and, finally, uremia. Malondialdehyde (MDA) is a product derived from peroxidation of polyunsaturated fatty acids and related esters. Evaluation of MDA in serum represents a non-invasive biomarker of oxidative stress. Prostate-specific antigen (PSA) is a sensitive marker for prostatic hypertrophy and cancer. We analyzed MDA serum levels to evaluate the oxidative stress in BPH. To this end, 22 BPH patients and 22 healthy donors were enrolled. Data show an increase of MDA level in BPH patients and a positive correlation between PSA and MDA levels. In conclusion, we describe a previously unknown relationship between PSA and MDA as an index of inflammation and oxidative stress in BPH. Keywords and phrases: Benign prostate hypertrophy, Malondialdehyde, Prostate-specific antigen.
Mayo Clinic - Mayo Clinic Finds Kidney Disease Associated With "Benign" Prostate
Men who experience signs and symptoms of a prostate obstruction resulting Researchers believe that with age the prostate becomes more susceptible to the
http://www.mayoclinic.org/news2005-rst/2899.html

Extractions: Home About Mayo Clinic Jobs Contact Us Mayo Clinic Locations: Arizona Florida Minnesota Mayo Clinic News News Current Releases Rochester, Minn. Jacksonville, Fla. Arizona ... Medical Services Mayo Clinic in Rochester Tuesday, June 28, 2005 Additional Resources For appointments or more information, call the Central Appointment Office at 507-284-2111. Other Web Resource: Becoming a Patient Journalists: newsbureau@mayo.edu ROCHESTER, Minn. Men who experience signs and symptoms of a prostate obstruction resulting from benign prostatic hyperplasia (BPH) are three times more likely than other men to develop chronic kidney disease, according to findings of a Mayo Clinic study published in this month's edition of Kidney International "This is the first study on the topic to sample the general community," says Andrew Rule, M.D., the Mayo Clinic kidney specialist who conducted the study with epidemiologist Steven Jacobsen, M.D., Ph.D. "Symptomatic and non-symptomatic men were compared, unlike clinical trials and studies in a urology practice, which tend to represent only symptomatic men."

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

101-111 of 111 Back | 1 | 2 | 3 | 4 | 5 | 6